Hypertension Management: Complete Treatment and Monitoring Guide

Understanding Hypertension Management

Hypertension (high blood pressure) is the leading modifiable risk factor for cardiovascular disease, affecting nearly 50% of adults in the United States and 1.3 billion worldwide. Despite effective treatments, only ~25% of hypertensive adults have their BP controlled to target levels.

The goal of hypertension management isn't just number normalization—it's cardiovascular risk reduction. Each 10 mmHg reduction in systolic BP reduces major cardiovascular disease events by 20%, stroke by 27%, heart failure by 28%, and all-cause mortality by 13%.

Blood Pressure Classification and Targets

ACC/AHA 2017 Categories

| Category | Systolic (mmHg) | Diastolic (mmHg) | Management | |----------|----------------|------------------|------------| | Normal | ＜120 | ＜80 | No treatment, healthy lifestyle | | Elevated | 120-129 | ＜80 | Lifestyle modification | | Hypertension Stage 1 | 130-139 | 80-89 | Lifestyle ± medications (if high risk) | | Hypertension Stage 2 | ≥140 | ≥90 | Medications + lifestyle | | Hypertensive Crisis | ＞180 | ＞120 | Emergency care |

Target Blood Pressure by Population

Diagnosis and Monitoring

Accurate BP Measurement

Proper Technique:

1. Rest: Sit quietly for 5 minutes before measurement
2. Position: Feet flat on floor, back supported, arm at heart level
3. Cuff size: Appropriate size (80% of arm circumference)
4. No caffeine/exercise/tobacco: 30 minutes before measurement
5. Empty bladder: Full bladder can raise BP 10-15 mmHg
6. Two readings: 1 minute apart, average both

Common errors:

• Cuff over clothing: Adds 5-50 mmHg (depending on clothing thickness)
• Talking during measurement: Adds 10-15 mmHg
• Unsupported arm: Adds 5-10 mmHg
• Crossed legs: Adds 5-8 mmHg
• Small cuff: Overestimates BP (very common error)

Out-of-Office Validation

Home BP Monitoring (HBPM):

• Equipment: Validated upper arm cuff (avoid wrist/finger devices)
• Schedule: Twice daily (morning and evening), 3-7 consecutive days
• Record: Keep log, bring to clinic
• Target: Home BP typically 5/5 mmHg lower than clinic BP
• Advantages: More reliable than clinic BP (no white coat effect), predicts outcomes better

Ambulatory BP Monitoring (ABPM):

• Method: 24-hour BP monitoring (every 20-30 min day, 30-60 min night)
• Indications: Suspected white coat hypertension, resistant hypertension, episodic hypertension
• Targets: ＜130/80 daytime, ＜110/65 nighttime
• Diagnosis: White coat hypertension (high clinic, normal out-of-office), masked hypertension (normal clinic, high out-of-office)

Treatment Strategies

Nonpharmacologic Therapy (First-Line for All)

Weight Loss:

• Impact: 1 kg weight loss → 1 mmHg BP reduction
• Target: BMI 18.5-24.9, or ≥5% weight loss if overweight
• Benefit: Most effective lifestyle intervention for BP

Dietary Approaches:

| Diet | Key Features | BP Reduction | Adherence | |------|-------------|--------------|-----------| | DASH diet | Low sodium, high fruits/vegetables, low-fat dairy | 11/6 mmHg | Moderate | | Low sodium | ＜1500 mg sodium/day | 5-7/2-4 mmHg | Difficult | | Mediterranean | High monounsaturated fats, plant-based | 5-10/2-5 mmHg | Good | | Vegetarian | Plant-based, no meat | 5-8/2-3 mmHg | Variable |

DASH Diet Details:

• 9-12 servings fruits/vegetables daily
• 2-3 servings low-fat dairy
• Whole grains, nuts, legumes
• Limited red meat, sweets, saturated fat
• Sodium: Initially ＜2300 mg, ideally ＜1500 mg

Physical Activity:

• Aerobic exercise: 150 min/week moderate intensity (30 min 5x/week)
  • Examples: Walking, cycling, swimming
  • BP reduction: 5-8/2-5 mmHg
• Resistance training: 2-3x/week
  • Examples: Weight machines, free weights, resistance bands
  • BP reduction: 3-5/2-3 mmHg
• Isometric exercise: Handgrip, leg exercises
  • BP reduction: 4-5/2-3 mmHg (emerging evidence)

Sodium Reduction:

• Current intake: Most Americans consume 3400 mg sodium/day
• Target: ＜2300 mg initially, ＜1500 mg ideal
• Strategies:
  • Avoid processed foods (major sodium source)
  • Don't add salt at table
  • Use herbs, spices, lemon juice for flavor
  • Read labels (sodium hides in many foods)
• Expected reduction: 2-8/1-4 mmHg (individual variability)

Potassium Increase:

• Target: 3500-4700 mg/day (current intake ~2600 mg)
• Food sources: Bananas, oranges, potatoes, beans, yogurt
• Caution: With CKD or certain medications (ACEi, ARB, spironolactone), limit potassium

Alcohol Moderation:

• Men: ≤2 drinks daily
• Women: ≤1 drink daily
• Benefit: Reduction of 2-4/1-2 mmHg
• One drink: 12 oz beer, 5 oz wine, 1.5 oz 80-proof liquor

Pharmacologic Therapy

First-Line Agents (Choose based on comorbidities):

| Class | Examples | Best For | Dose | Side Effects | |-------|----------|-----------|------|--------------| | Thiazide diuretics | Chlorthalidone, HCTZ | General population, heart failure | HCTZ 12.5-50 mg qd | Hypokalemia, hyponatremia, hyperuricemia, hyperglycemia | | ACE inhibitors | Lisinopril, Enalapril | Diabetes, CKD, HFrEF | Lisinopril 10-40 mg qd | Cough (10%), hyperkalemia, angioedema (rare) | | ARBs | Losartan, Valsartan | ACEi cough, diabetes, CKD | Losartan 25-100 mg qd | Hyperkalemia, less cough than ACEi | | CCBs | Amlodipine, Nifedipine | Elderly, angina, Black patients | Amlodipine 2.5-10 mg qd | Edema, headache, flushing, constipation | | Thiazide-like | Indapamide, Chlorthalidone | Elderly, osteoporosis risk | Indapamide 1.25-2.5 mg qd | Similar to HCTZ but potentially better outcomes |

Second-Line/Add-on Agents:

• Beta-blockers: Carvedilol, metoprolol (HFrEF, post-MI, tachyarrhythmia)
• Alpha-blockers: Doxazosin, terazosin (BPH, resistant hypertension)
• Aldosterone antagonists: Spironolactone, eplerenone (resistant hypertension)
• Vasodilators: Hydralazine, minoxidil (pregnancy, resistant hypertension)

Medication Selection by Comorbidity:

| Comorbidity | Preferred First-Line | Avoid/Use Caution | |-------------|---------------------|-------------------| | Diabetes | ACEi or ARB (renal protection) | Thiazides (worsen hyperglycemia) | | CKD | ACEi or ARB (renoprotective) | ACEi/ARB if hyperkalemia, AKI | | HFrEF | ACEi/ARNI + Beta-blocker + MRA | CCB (negative inotrope) | | CAD/Post-MI | Beta-blocker + ACEi/ARB | Short-acting CCB (avoid) | | Atrial fibrillation | ACEi/ARB or Beta-blocker | Non-DHP CCB (verapamil, diltiazem) | | BPH | Alpha-blocker | Add if on BP medications | | Pregnancy | Labetalol, Nifedipine, Methyldopa | ACEi, ARB (teratogenic) | | Elderly | Thiazide-like, CCB | Multiple medications, overtreatment |

Treatment-Resistant Hypertension

Definition: BP ≥130/80 despite 3 antihypertensives (including diuretic) at optimal doses

Prevalence: 10-15% of hypertensive patients

Causes:

• Pseudo-resistance (most common):

  • Poor adherence (50% of resistant cases)
  • White coat effect (20-30%)
  • Improper BP measurement technique
  • Medication interactions (NSAIDs, decongestants, stimulants)

• True resistance:

  • Secondary hypertension (20%): Primary aldosteronism, renal artery stenosis, OSA
  • Volume overload: High sodium intake, inadequate diuretic
  • Obstructive sleep apnea
  • CKD progression

Evaluation:

1. Confirm adherence (pill counts, pharmacy refills)
2. Home BP monitoring or ABPM (rule out white coat)
3. Screen for secondary causes if BP truly resistant:
   • Aldosterone-renin ratio (primary aldosteronism)
   • Renal ultrasound (renal artery stenosis)
   • Sleep study (OSA)
   • Thyroid function

Treatment:

• Optimize diuretic (consider chlorthalidone instead of HCTZ)
• Add spironolactone (most effective add-on)
• Consider ACEi/ARB + CCB combination (if not already)
• Treat secondary cause if identified

Monitoring and Follow-up

Laboratory Monitoring

Baseline (before starting medications):

• BMP (electrolytes, creatinine, glucose)
• Lipid panel
• TSH
• Urinalysis (protein, albumin/creatinine ratio)
• ECG (left ventricular hypertrophy)

Follow-up (1-4 weeks after starting/changing meds):

• BMP: Check potassium and creatinine (ACEi/ARB, diuretics)
  • Expected: Creatinine ↑ up to 30% (acceptable, due to BP effect)
  • Concern: Creatinine ↑ ＞30% or hyperkalemia (＞5.0 mEq/L)
• Symptoms: Orthostatic symptoms, edema, cough

Long-term (every 6-12 months):

• BMP, lipids
• Urinalysis (if CKD)
• Medication side effect review

Frequency of Follow-up

| Situation | Follow-up Frequency | |-----------|---------------------| | Initiating treatment | Every 4 weeks until BP at target | | At target | Every 3-6 months | | Dose adjustment | Every 2-4 weeks | | Resistant hypertension | Every 4-6 weeks or more frequently | | Medication changes | 2-4 weeks after each change |

Emergency Situations

Lifestyle Maintenance

Long-term Adherence Strategies

Medication adherence:

• Pill organizers: Weekly or monthly organizers
• Reminder systems: Phone alarms, pill box alarms
• Combination pills: Single pill with 2-3 medications
• Align with routine: Take with regular activity (breakfast, brushing teeth)

Dietary adherence:

• Meal planning: Plan meals in advance
• DASH diet recipes: Resources online, cookbooks
• Read labels: Sodium content everywhere
• Cook at home: Control over ingredients

Exercise adherence:

• Schedule it: Same time daily
• Variety: Mix activities to prevent boredom
• Find a buddy: Exercise partner increases adherence
• Track progress: BP readings, weight, activity logs

Home Monitoring Schedule

Once at target:

• Weekly: Check BP 2-3 times per week
• Record: Keep log (paper or app)
• Bring to clinic: Every visit
• Detect trends: Rising BP warrants earlier clinic visit

When changing therapy:

• Daily: Check BP twice daily (morning and evening)
• For 1-2 weeks: Until stable at new target
• Then resume: Weekly monitoring

Related Conditions

• Coronary Artery Disease: Major complication of hypertension
• Heart Failure: Hypertension is leading cause
• Chronic Kidney Disease: Both cause and consequence of hypertension

FAQ

References